The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.

Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with ...

The company, which has not received any complaints related to the issue, previously discontinued the devices affected by the expanded recall. The company wrote to customers on July 8 to flag potential ...

Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the ...

The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, included $435 million upfront and up to ...

Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a ...

The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several ...

BD named Vitor Roque as chief financial officer Thursday, ending the medtech company’s seven-month search for a permanent ...

Mobia Medical, a company that makes a neurostimulation device for stroke treatment, made its public debut on Friday. The medtech startup wants to help stroke survivors recover arm function sooner ...

The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device. Tandem Diabetes Care ...

With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.